News

Bausch Health is set to report Q1 2026 earnings after market close today, April 29, 2026, with analysts forecasting a 37% EPS increase driven by key product performance amid patent pressures.

Hong Kong government has inked agreements with 22 technology companies, including Pfizer, to enhance innovation in life and health technologies within the region.

Hong Kong government signed agreements with 22 companies, including pharmaceutical giant Pfizer, to establish or expand operations in life and health technology, attracting significant investments and jobs.

Biopharma companies are increasingly outsourcing drug manufacturing to Europe, particularly Germany, to diversify supply chains amid U.S. tariff pressures and global uncertainties.

Eli Lilly is using predictive algorithms and vision AI to identify bottlenecks and inspect vials at unprecedented speeds, scaling manufacturing without new facilities.

Hong Kong has signed agreements with 22 companies, including pharmaceutical giant Pfizer, to establish or expand operations in life and health technology sectors.

The European Economic and Social Committee has adopted an opinion calling for accelerated biotechnology development in Europe to prevent falling behind global competitors.

Hong Kong government inks deals with 22 companies, including pharmaceutical giant Pfizer, to establish or expand operations in life and health technology and other strategic sectors.

Chinese biopharma companies have driven a 132% increase in innovative drug out-licensing deals totaling $56.7 billion across 44 transactions since early 2026, underscoring China's rising dominance in the global pharmaceutical sector.

The European Economic and Social Committee has issued an opinion pushing the EU to boost biotechnology through streamlined regulations, investments, and a unified ecosystem to keep pace with global rivals.